Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun 15;28(1):17.
doi: 10.1186/s40885-022-00202-9.

A clinical algorithm to determine target blood pressure in the elderly: evidence and limitations from a clinical perspective

Affiliations
Review

A clinical algorithm to determine target blood pressure in the elderly: evidence and limitations from a clinical perspective

Jinho Shin et al. Clin Hypertens. .

Abstract

As the elderly population is growing rapidly, management of hypertension in South Korea faces major challenges because the proportion of elderly hypertension patients is also increasing. The characteristics of this population are also much more complex than younger patients. Elderly hypertension is characterized by wide variations in (1) fitness or biological age, (2) white-coat effect, (3) poor functional status or frailty, (4) dependency in activities of daily living or institutionalization, (5) orthostatic hypotension, and (6) multiple comorbidities. All of these should be considered when choosing optimal target blood pressure in individual patients. Recent randomized clinical trials have shown that the benefits of intensive blood pressure control for elderly patients is greater than previously thought. For generalization of these results and implementation of the guidelines based on these studies, defining the clinician's role for individualization is critically important. For individualized decisions for target blood pressure (BP) in the elderly with hypertension, four components should first be checked. These consist of (1) the minimum requirement of functional status and capability of activities of daily living, (2) lack of harmful evidence by the target BP, (3) absence of white-coat hypertension, and (4) standing systolic BP ≥ 110 mmHg without orthostatic symptoms. Risk of decreased organ perfusion by arterial stenosis should be screened before starting intensive BP control. When the target BP differs among comorbidities, the lowest target BP should be given preference. After starting intensive BP lowering therapy, tolerability should be monitored, and the titration should be based on the mean level of blood pressure by office supplemented by out-of-office BPs. Applications of the clinical algorithms will be useful to achieve more standardized and simplified applications of target BP in the elderly.

Keywords: Aged; Algorithms; Antihypertensives agents; Frailty; Hypertension; Hypotension.

PubMed Disclaimer

Conflict of interest statement

Jinho Shin received grants from Sanofi and Hanmi and honoraria from Sankyo, Menarini, Daewoong, Boryong, Daewon, Bayer, Viatris, and Dongwha. Kwang-il Kim received research grants from Hanmi, Boryong, Sankyo and honoraria from Sankyo, Daewoong, Boryong, Viatris.

Figures

Fig. 1
Fig. 1
Individualized algorithm for target blood pressure (BP) according to different tolerability profiles in patients with multiple comorbidities. ASCVD, atherosclerotic cardiovascular diseases; CKD, chronic kidney diseases; e.g., for example; LAD, large artery disease. a)Grade of recommendation: IIa, should be considered in favor of usefulness/efficacy; b)IIb, may be considered with less-well established efficacy; c)III, not recommended
Fig. 2
Fig. 2
Practical algorithm for target blood pressure in individual elderly patients according to tolerability factors and the different target BPs among multiple comorbidities. ABPM, ambulatory blood pressure monitoring; ADL, activities of daily living; BP, blood pressure; HBPM, home blood pressure monitoring; OH, orthostatic hypotension; SBP, systolic BP; WCE, white-coat effect

Similar articles

Cited by

References

    1. World Health Organization (WHO). A global brief on hypertension: silent killer, global public health crisis: World Health Day 2013 [Internet]. Geneva: WHO; 2013 [cited 3 February 2022]. Available from: https://apps.who.int/iris/handle/10665/79059.
    1. Buckley LF, Dixon DL, Wohlford GF, 4th, Wijesinghe DS, Baker WL, Van Tassell BW. Intensive versus standard blood pressure control in SPRINT-eligible participants of ACCORD-BP. Diabetes Care. 2017;40:1733–8. - PubMed
    1. World Health Organization (WHO) Global health and aging. Geneva: WHO; 2011.
    1. Kim KW, Kim OS. Super aging in South Korea unstoppable but mitigatable: a sub-national scale population projection for best policy planning. Spat Demogr. 2020;8:155–73. - PMC - PubMed
    1. Korean Society Hypertension (KSH), Hypertension Epidemiology Research Working Group. Kim HC, Cho MC. Korea hypertension fact sheet 2018. Clin Hypertens. 2018;24:13. - PMC - PubMed

LinkOut - more resources